PURE Bioscience, Inc. (OTCMKTS:PURE) Short Interest Up 1,000.0% in January

PURE Bioscience, Inc. (OTCMKTS:PURE) was the target of a large increase in short interest in January. As of January 15th, there was short interest totalling 4,400 shares, an increase of 1,000.0% from the December 31st total of 400 shares. Based on an average trading volume of 233,200 shares, the days-to-cover ratio is presently 0.0 days.

PURE Bioscience Price Performance

Shares of PURE Bioscience stock traded up $0.00 during trading hours on Wednesday, reaching $0.07. The company had a trading volume of 100,915 shares, compared to its average volume of 78,395. The business has a fifty day simple moving average of $0.07 and a 200 day simple moving average of $0.08. PURE Bioscience has a one year low of $0.06 and a one year high of $0.16. The firm has a market cap of $8.21 million, a PE ratio of -1.84 and a beta of 0.07.

PURE Bioscience (OTCMKTS:PURE) last posted its quarterly earnings data on Monday, December 16th. The company reported ($0.01) earnings per share (EPS) for the quarter.

About PURE Bioscience

PURE Bioscience, Inc develops and commercializes antimicrobial products that provide solutions to the health and environmental challenges of pathogen and hygienic control in the United States and internationally. The company manufactures and distributes silver dihydrogen citrate (SDC), a non-toxic antimicrobial agent, which offers residual protection, as well as formulates with other compounds.